Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
Rheumatoid arthritis (RA) is an autoimmune disease affecting approximately 1% of the population. Patients have reduced life expectancy and the leading cause of death is cardiovascular disease (CVD), with patients experiencing at least a 2-fold increased risk of myocardial infarction. RA is recognize...
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
2011
|